No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹695Prev. Close
₹699.6Turnover(Lac.)
₹656.48Day's High
₹698.45Day's Low
₹664.6552 Week's High
₹73352 Week's Low
₹440Book Value
₹373.41Face Value
₹10Mkt Cap (₹ Cr.)
1,341.09P/E
15.98EPS
43.85Divi. Yield
0.2629 Aug 2025
12:00 AM
AGM
Announcement Date: 29 Aug, 2025
29 Aug 2025
12:00 AM
BookCloser
4 Feb 2026
12:00 AM
Board Meeting
Agenda : Audited Result
22 May 2025
12:00 AM
Dividend
Dividend Amount: 1.8
Record Date: 12 Sep, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 20.03 | 20.03 | 20.03 | 20.03 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 651.64 | 572.81 | 482.44 | 412.85 |
Net Worth | 671.67 | 592.84 | 502.47 | 432.88 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 376.08 | 324.95 | 304.27 | 310.81 |
yoy growth (%) | 15.73 | 6.79 | -2.1 | 39.21 |
Raw materials | -186.77 | -171.16 | -172.67 | -203.65 |
As % of sales | 49.66 | 52.67 | 56.74 | 65.52 |
Employee costs | -54.89 | -47.5 | -35.05 | -26.73 |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | 64.04 | 43.09 | 35.74 | 30.05 |
Depreciation | -5.46 | -4.39 | -3.85 | -3.21 |
Tax paid | -14.48 | -10.34 | -8.33 | -8.31 |
Working capital | -8.51 | 25.15 | 13.34 | -4.84 |
Other operating items |
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 15.73 | 6.79 | -2.1 | 39.21 |
Op profit growth | 29.17 | 8 | 30.85 | 40.73 |
EBIT growth | 39.41 | 15.08 | 15.61 | 39.5 |
Net profit growth | 51.3 | 19.53 | 26.01 | 47.2 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 623.23 | 580.55 | 510.31 | 472.12 | 424.19 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 623.23 | 580.55 | 510.31 | 472.12 | 424.19 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 22.48 | 34.42 | 22.47 | 10 | 5.66 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,845.7 | 102.94 | 4,49,251.48 | 705.44 | 0.85 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,644 | 69.28 | 1,78,242.24 | 598 | 0.45 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,381.9 | 68.48 | 1,52,951.96 | 577 | 0.13 | 2,547 | 249.82 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270 | 23.02 | 1,06,811.05 | 90.6 | 0.62 | 4,266.4 | 377.55 |
Cipla Ltd CIPLA | 1,292.3 | 23 | 1,05,391.4 | 616.88 | 1.23 | 4,256.93 | 411.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Kishorbhai M Shah
ED / MD / Promoter
Mahendra G Patel
WTD & Executive Director
Hasmukhbhai I Patel
WTD & Executive Director
Ashish Rajanikant Patel
WTD & Executive Director
Munjal Mahendrabhai Patel
Non-Exec & Non-Independent Dir
Rajnikant G Patel
Independent Non Exe. Director
Saurin Jagdish Bhai Parikh
Independent Non Exe. Director
Nareshkumar Pirabhai Suthar
Independent Non Exe. Director
Seema Mehta
Company Sec. & Compli. Officer
Trusha Shah
Lincoln House B/H Satyam Compe,
Science City Road Sola,
Gujarat - 380060
Tel: 91-079-67778000
Website: http://www.lincolnpharma.com
Email: cs@lincolnpharma.com; investor@lincolnpharma.com
5th Floor 506 to 508,
ABC-I Off C G Road, Navrangpura,
Ahmedabad-380009
Tel: 91-79-26465179
Website: https://in.mpms.mufg.com/
Email: ipo.team@linkintime.co.in
Summary
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converte...
Read More
Reports by Lincoln Pharmaceuticals Ltd
What is the Lincoln Pharmaceuticals Ltd share price today?
What is the Market Cap of Lincoln Pharmaceuticals Ltd?
What is the PE and PB ratio of Lincoln Pharmaceuticals Ltd?
What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd?
What is the CAGR of Lincoln Pharmaceuticals Ltd?
What is the shareholding pattern of Lincoln Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
